| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.82▼ | 2.85▼ | 2.83▼ | 3.17▼ | 3.91▼ |
| MA10 | 2.82▼ | 2.83▼ | 2.90▼ | 3.59▼ | 4.35▼ |
| MA20 | 2.82▼ | 2.92▼ | 3.02▼ | 3.98▼ | 4.61▼ |
| MA50 | 2.82▼ | 3.12▼ | 3.50▼ | 4.46▼ | 4.74▼ |
| MA100 | 2.93▼ | 3.59▼ | 3.83▼ | 4.67▼ | 5.40▼ |
| MA200 | 3.23▼ | 3.90▼ | 4.31▼ | 4.62▼ | 5.70▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.011▲ | 0.007▲ | -0.124▼ | -0.171▼ |
| RSI | 47.382▼ | 36.285▼ | 29.991▼ | 17.879▼ | 31.770▼ |
| STOCH | 53.888 | 59.164 | 23.669 | 6.086▼ | 21.719 |
| WILL %R | -57.143 | -78.049▼ | -83.333▼ | -95.041▼ | -96.578▼ |
| CCI | -1.961 | -32.184 | -70.669 | -165.913▼ | -257.390▼ |
|
Wednesday, October 28, 2026 01:01 AM
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces a poster presentation at the ...
|
|
Wednesday, October 14, 2026 05:02 AM
Coya is currently conducting the ALSTARS Trial, a Phase 2/3, randomized, multi-center, double-blind, placebo-controlled study to evaluate the efficacy and safety of COYA 302 for the treatment of ALS ...
|
|
Tuesday, May 12, 2026 04:30 AM
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 05/11/26 | 3.00 | 3.00 | 2.72 | 2.81 | 310,142 |
| 04/11/26 | 3.28 | 3.40 | 2.98 | 3.08 | 195,395 |
| 03/11/26 | 3.26 | 3.405 | 3.03 | 3.11 | 518,249 |
| 02/11/26 | 3.64 | 3.89 | 3.175 | 3.23 | 270,200 |
| 30/10/26 | 3.96 | 4.085 | 3.5937 | 3.61 | 214,740 |
| 29/10/26 | 4.08 | 4.20 | 3.95 | 3.98 | 70,106 |
| 28/10/26 | 4.09 | 4.175 | 4.045 | 4.06 | 150,844 |
| 27/10/26 | 3.97 | 4.30 | 3.94 | 4.12 | 55,827 |
| 26/10/26 | 3.95 | 4.03 | 3.91 | 3.95 | 129,573 |
| 23/10/26 | 4.08 | 4.245 | 3.935 | 3.94 | 188,644 |
|
|
||||
|
|
||||
|
|